The primary purpose of the Saving tiny Hearts Society is to raise money to fund life saving research projects to improve, prolong and save the lives of those affected by Congenital Heart Defects.
We are honored to have a Medical Advisory Board (MAB) comprised of an elite group of world-renowned cardiothoracic surgeons, researchers and cardiologists. The MAB vets and determines which research projects the Saving tiny Hearts Society will fund. With the help of our MAB, money raised is allocated to fund the most promising research of number one birth defect worldwide.
2019 Grant Application
The Saving tiny Hearts Society awards research grants to early stage science with unique hypotheses fostering the next generation of congenital heart defect research creating a strong foundation of preliminary evidence to make scientific advancements.
As a private, not-for-profit source of funds for scientists studying congenital heart defects, the Saving tiny Hearts Society focuses its funding on investigator-initiated, peer-reviewed proposals. This process ensures that researchers propose projects they believe are ready to be tackled with the available knowledge and techniques. This intellectual freedom encourages discovery in areas that scientists
believe are most likely to determine hidden causes and discover cures to prolong, improve and save the lives of all children afflicted with congenital heart defects.
To streamline the grant application process, an electronic link has been provided below to download the Saving tiny Hearts Society 2019 Grant Application. If you have additional questions regarding our application process, please email, Larry Kluge, Medical Advisory Board Liaison at: firstname.lastname@example.org
($375,000 total allocation, plus an additional $125,000 based on significant progress)
Cancer Risk Related to Low Dose Ionizing Radiation from Cardiac Imaging in Congenital Heart Disease: A Molecular Study
Surgical Outcomes in Anomalous Aortic Origin of a Coronary Artery: A Molecular Study
A Novel Therapeutic Paradigm for Congenital Arrhythmias
Improving Transfusion Efficacy Following Surgical Repair of Pediatric Congenital Heart Defects
Genetic Regulation of Cardiac Pacemaker Cell Specification
($370,000 total allocation)
Defining a Novel Pathway for Pediatric Sudden Cardiac Death
Investigation of Wntless in Heart Regeneration
Gene Editing Treatment of Catecholaminergic Polymorphic Ventricular Tachycardia
Mechanisms of Cardiomyocyte Renewal Regulated by Nkx2.5
Pedigree-Adapted Use of Genomic Sequencing for Deciphering Syndromic and Non Syndromic Congenital Heart Malformations
Design of Mechanical Circulatory Support for Failing Fontan Circulation
Creation of a Chronic Animal Model of Fontan Circulation Using Transcatheter Techniques
Stimulating Cardiomyocyte Proliferation as a Novel Therapy for CHD
Cardiac Energy Signature and Heart Failure in Congenital Heart Disease
($328,000 total allocation)
Role of NOX-4 Dependent Notch1 Dysregulations on Cardiac Development in Fetal Alcohol Syndrome
Novel Arrhythmia Mechanisms in Long QT Syndrome
Feasibility of a Novel Fontan Right-Side Assist Device
Neuroprotective Strategies in Pediatric Surgery
Elucidating the Genetics and Epigenetics of Congenital Heart Defects Using Zebrafish Genome Engineering
The Effects of Pediatric-Specific HCM Mutations in B-Cardiac Myosin Power Generation